This week Prostate.Carcinoma.ai will be presented by our partner Mint Medical at the RSNA Annual Meeting in Chicago. Our plug-in Software is designed to enhance prostate MRI analysis and is fully integrated into mint Lesion™. Mint Medical chose our solution to automate and accelerate prostate MR evaluations based on PI-RADS 2.1 guidelines, improving workflow and accuracy for radiologists.

Integrated in mintLesion™, Prostate.Carcinoma.ai segments the prostate gland, its zones, and suspicious lesions. Radiologists are asked to accept, to adapt or delete these findings to maintain the full control. mint Lesion maps each accepted finding to the standardized prostate lesion scheme, eliminating the need for time-consuming manual lesion annotation and drawing.

This year, Andreas Raguse visits the RSNA. He is the on-site contact person from FUSE-AI and supports the mintLesion™ team in answering visitors' questions about our software. He is also in contact with other PACS and DICOM viewer manufacturers who would like to integrate our solution into their software.

The Radiological Society of North America (RSNA) is an annual medical conference held in Chicago at the end of the year. It is one of the largest and most important events worldwide and brings together hundreds of exhibitors and thousands of participants from all over the world.